JOHNSON & JOHNSON

JOHNSON & JOHNSON

Displaying 10 out of 51 results

  1. The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

    Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook

    Johnson & Johnson reported a 41.8per cent rise in second-quarter profit on Tuesday, helped by its pharmaceuticals business.
  2. The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

    Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end

    Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible ...
  3. FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York

    Johnson & Johnson faces US criminal probe over baby powder: Report

    The US Justice Department is pursuing a criminal probe into whether Johnson & Johnson lied about potential cancer risks of its talcum powder, ...
  4. New Content Item

    Wall St. notches all-time highs on lingering rate-cut optimism

  5. The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

    Johnson & Johnson to test experimental HIV vaccine in US, Europe

    Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in ...
  6. NYSE May29

    China trade tensions, growth worries sink Wall Street again

  7. State's attorney Brad Beckworth presents information in the opening statements during the Okla

    J&J's greed helped fuel US opioid crisis, Oklahoma claims at trial

  8. A Johnson & Johnson building is shown in Irvine, California

    FDA issues recall of J&J unit Ethicon's surgical staplers

    The U.S. Food and Drug Administration on Friday issued a recall of surgical staplers made by Johnson & Johnson's Ethicon unit, warning that the ...
  9. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    Johnson & Johnson to submit applications for at least 10 new drugs by 2023

    Johnson & Johnson said on Wednesday it expected to file marketing applications for at least 10 new drugs between 2019 to 2023, to strengthen its ...